175 related articles for article (PubMed ID: 3761322)
1. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside conjugates. 14. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids with improved water solubility.
Hong CI; Nechaev A; Kirisits AJ; Vig R; Hui SW; West CR
J Med Chem; 1995 May; 38(10):1629-34. PubMed ID: 7752187
[TBL] [Abstract][Full Text] [Related]
4. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
[TBL] [Abstract][Full Text] [Related]
5. 1-beta-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity.
Hong CI; West CR; Bernacki RJ; Tebbi CK; Berdel WE
Lipids; 1991 Dec; 26(12):1437-44. PubMed ID: 1819747
[TBL] [Abstract][Full Text] [Related]
6. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside conjugates. 13. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of thioether lipids with improved water solubility.
Hong CI; Nechaev A; Kirisits AJ; Vig R; West CR
J Med Chem; 1993 Jun; 36(12):1785-90. PubMed ID: 8510106
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
Schott H; Schwendener RA
Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside conjugates. 6. Synthesis and comparison of antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids and selected lipophilic alcohols.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Med Chem; 1985 Feb; 28(2):171-7. PubMed ID: 3968680
[TBL] [Abstract][Full Text] [Related]
11. 1-beta-D-arabinofuranosylcytosine-phospholipid conjugates as prodrugs of Ara-C.
Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Ryu EK; MacCoss M
Cancer Drug Deliv; 1984; 1(3):181-90. PubMed ID: 6544120
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of optical isomers of ether and thioether lipids.
Hong CI; An SH; Nechaev A; Kirisits AJ; Vig R; West CR
Lipids; 1993 Nov; 28(11):1021-6. PubMed ID: 8277825
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-beta-D-arabinofuranosylcytosine 5-diphosphate-L-1,2-diacylglycerols.
Ryu EK; Ross RJ; Matsushita T; MacCoss M; Hong CI; West CR
J Med Chem; 1982 Nov; 25(11):1322-9. PubMed ID: 7143370
[TBL] [Abstract][Full Text] [Related]
14. Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates.
Novotný L; Balázová E; Sandula J; Ujházy V; Kéry V
Int J Cancer; 1991 Jan; 47(2):281-4. PubMed ID: 1988371
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice.
Berdel WE; Okamoto S; Danhauser-Riedl S; Hong CI; Winton EF; West CR; Rastetter J; Vogler WR
Exp Hematol; 1989 May; 17(4):364-7. PubMed ID: 2707318
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T
Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
[TBL] [Abstract][Full Text] [Related]
20. Influence of 1-beta-D-arabinofuranosylcytosine conjugates of lipids on the growth and metastasis of Lewis lung carcinoma.
Berdel WE; Danhauser S; Hong CI; Schick HD; Reichert A; Busch R; Rastetter J; Vogler WR
Cancer Res; 1988 Feb; 48(4):826-9. PubMed ID: 3338080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
